ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
lovethespeccies
|
1.3K |
319K |
17 |
15:17 |
15:17 |
ASX - By Stock
|
1.3K
|
319K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
lovethespeccies
|
59 |
9.8K |
11 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
59
|
9.8K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
IMUOD
|
|
lovethespeccies
|
63 |
25K |
7 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
63
|
25K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
lovethespeccies
|
261 |
62K |
10 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
62K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
lovethespeccies
|
261 |
62K |
12 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
62K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
lovethespeccies
|
261 |
62K |
2 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
62K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
lovethespeccies
|
1.3K |
319K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
1.3K
|
319K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and Kincell Bio Announce Strategic Partnership
|
|
lovethespeccies
|
144 |
63K |
21 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
144
|
63K
|
21
|
|
ASX - By Stock
|
IMU |
Re:
Presentation!
|
|
lovethespeccies
|
106 |
34K |
20 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
106
|
34K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
lovethespeccies
|
55 |
14K |
13 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
55
|
14K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
lovethespeccies
|
58 |
17K |
11 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
58
|
17K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
lovethespeccies
|
33 |
8.5K |
13 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
33
|
8.5K
|
13
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: AVZI Successfully Defends Against Jin Cheng ICC Proceedings
|
|
lovethespeccies
|
421 |
196K |
54 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
421
|
196K
|
54
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
lovethespeccies
|
126 |
31K |
13 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
31K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
lovethespeccies
|
126 |
31K |
5 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
31K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Singapore Healthcare Day Presentation
|
|
lovethespeccies
|
63 |
16K |
10 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
63
|
16K
|
10
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Disputes Update
|
|
lovethespeccies
|
240 |
84K |
3 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
240
|
84K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Big Pharma buyouts.
|
|
lovethespeccies
|
39 |
9.3K |
4 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
39
|
9.3K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
lovethespeccies
|
1.3K |
319K |
15 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
1.3K
|
319K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Half Yearly Report and Accounts
|
|
lovethespeccies
|
143 |
68K |
43 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
143
|
68K
|
43
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
lovethespeccies
|
1.3K |
319K |
8 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
1.3K
|
319K
|
8
|
|
ASX - By Stock
|
ATG |
Re:
Ann: 1HFY24 Investor Presentation
|
|
lovethespeccies
|
14 |
6.9K |
0 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
14
|
6.9K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
lovethespeccies
|
209 |
49K |
19 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
209
|
49K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
lovethespeccies
|
114 |
32K |
9 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
114
|
32K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
lovethespeccies
|
1.3K |
319K |
11 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
1.3K
|
319K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
lovethespeccies
|
1.3K |
319K |
10 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
1.3K
|
319K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
lovethespeccies
|
1.3K |
319K |
12 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
1.3K
|
319K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
lovethespeccies
|
1.3K |
319K |
12 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
1.3K
|
319K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
lovethespeccies
|
1.3K |
319K |
11 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
1.3K
|
319K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
lovethespeccies
|
1.3K |
319K |
15 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
1.3K
|
319K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Doses First Intravenous Patient
|
|
lovethespeccies
|
104 |
57K |
6 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
104
|
57K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Doses First Intravenous Patient
|
|
lovethespeccies
|
104 |
57K |
3 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
104
|
57K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Doses First Intravenous Patient
|
|
lovethespeccies
|
104 |
57K |
5 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
104
|
57K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
lovethespeccies
|
197 |
51K |
12 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
197
|
51K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
lovethespeccies
|
1.3K |
319K |
10 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
1.3K
|
319K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
lovethespeccies
|
323 |
75K |
10 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
323
|
75K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Trial Centre Monepantel Pharmaust
|
|
lovethespeccies
|
8 |
1.9K |
10 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
8
|
1.9K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
lovethespeccies
|
323 |
75K |
13 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
323
|
75K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
lovethespeccies
|
430 |
107K |
15 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
430
|
107K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
lovethespeccies
|
430 |
107K |
9 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
430
|
107K
|
9
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: AVZ Successful in ICSID Interim Measures
|
|
lovethespeccies
|
109 |
69K |
46 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
109
|
69K
|
46
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
lovethespeccies
|
430 |
107K |
15 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
430
|
107K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
lovethespeccies
|
430 |
107K |
11 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
430
|
107K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
lovethespeccies
|
430 |
107K |
8 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
430
|
107K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FightMND Invites PharmAust to Apply for Phase 2/3 Funding
|
|
lovethespeccies
|
56 |
15K |
10 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
56
|
15K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FightMND Invites PharmAust to Apply for Phase 2/3 Funding
|
|
lovethespeccies
|
56 |
15K |
7 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
56
|
15K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAAOA Top 20 & Distribution Report
|
|
lovethespeccies
|
43 |
11K |
5 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
43
|
11K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAAOA Top 20 & Distribution Report
|
|
lovethespeccies
|
43 |
11K |
3 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
43
|
11K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
IMU product line - HER-Vaxx
|
|
lovethespeccies
|
57 |
22K |
5 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
57
|
22K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
lovethespeccies
|
87 |
18K |
12 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
87
|
18K
|
12
|
|